Amsterdam

• Symbiotic-GU-06-A Study to Learn About the Study Medicine PF-08634404 Alone or In Combination With Enfortumab Vedotin in Adult Participants … Recruiting
  2025-523523-21-00 9 2026-07-03 Locally Advanced or Metastatic Urothelial Cancer
• A clinical trial to learn more about the effects of GIA632 in people with the most common type of vitiligo Recruiting
  2025-522301-37-00 4 2026-06-24 Nonsegmental vitiligo
• A trial to learn how safe durvalumab with chemotherapy is and how well it works in adults with muscle-invasive bladder cancer Recruiting
  2024-519246-75-01 4 2026-06-15 Patients With Muscle-Invasive Bladder Cancer
• PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer Recruiting
  2025-522883-34-00 6 2026-06-12 Metastatic cervical cancer
• AchilleS tendinoPathy treated with cortIcosteRoid injEctions. Recruiting
  2025-524057-13-00 5 2026-06-03 Achilles tendinopathy
• A phase 3 trial comparing elritercept versus epoetin alfa for treatment of anemia due to lower-risk MDS in ESA-naïve adults who require RBC … Recruiting
  2025-523544-12-00 5 2026-06-02 Myelodysplastic neoplasms/syndromes (MDS)
• MetAddon: Methadone as co-analgesic for patients with metastatic bone pain: a double-blind randomized controlled trial Recruiting
  2025-522710-22-00 6 2026-05-28 Cancer, bone metastasis, pain
• A Phase 3 Study Comparing JNJ-79635322 and an anti-BCMAxCD3 Bispecific Antibody in Participants with Relapsed or Refractory Multiple Myeloma Recruiting
  2025-522007-18-00 5 2026-05-27 Relapsed or Refractory Multiple Myeloma
• PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy f … Recruiting
  2023-506194-35-00 5 2026-05-22 Colorectal liver metastases
• Study to assess the efficacy and safety of Rina-S in participants with non-small cell lung cancer Recruiting
  2025-522107-18-00 4 2026-05-19 Locally advanced or metastatic Non-Small Cell Lung Cancer
• A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043) Recruiting
  2025-524160-38-00 5 2026-05-12 Renal Cell Carcinoma, hepatocellular carcinoma, nonMSI-H/dMMR colorect
• A clinical study of belzutifan and zanzalintinib in people with advanced kidney cancer (MK-6482-034) Recruiting
  2024-516993-31-00 5 2026-05-11 Renal Cell Carcinoma
• A clinical study to evaluate the effects of RO7795068 in participants with obesity or overweight without type 2 diabetes. Recruiting
  2025-523104-71-00 5 2026-05-08 Obesity or Overweight Without Type 2 Diabetes
• ESPRIT study Recruiting
  2024-519540-32-00 11 2026-05-06 post COVID
• HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting
  2025-523717-29-00 5 2026-04-28 HFpEF or HFmrEF and obesity
• Macrophage and monocyte presence in lupus nephritis before and during treatment Recruiting
  2025-522187-32-01 6 2026-04-23 Lupus Nephritis
• A clinical trial of sacituzumab tirumotecan to treat urothelial cancer (MK-2870-031) Recruiting
  2024-520014-22-00 5 2026-04-22 Locally advanced/metastatic urothelial carcinoma
• A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosi … Recruiting
  2025-521546-23-00 5 2026-04-21 Secondary progressive multiple sclerosis
• An investigational trial to evaluate the effects of the drug XC001 delivered via a catheter in subjects with chronic angina caused by corona … Recruiting
  2024-514874-36-01 4 2026-04-17 Refractory angina due to obstructive coronary artery disease
• Neoadjuvant gemcitabine and cisplatin in combination with perioperative pembrolizumab versus upfront surgery for patients with primary resec … Recruiting
  2024-516898-72-00 10 2026-04-17 Perihilar cholangiocarcinoma, distal cholangiocarcinoma
• A trial to learn how safe the combination of rilvegostomig and chemotherapy is and how well it works compared to durvalumab and chemotherapy … Recruiting
  2025-523085-24-00 5 2026-04-13 Biliary Tract Cancer
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants with Early Alzheimer’s Diseas … Recruiting
  2025-523515-11-00 1 2026-04-03 Early Alzheimer's Disease
• PHASE 1 STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF E-VIM VACCINE CVX1 WITH OR WITHOUT ICI IN THE TREATMENT OF SUBJECTS … Recruiting
  2025-523781-25-00 1 2026-04-02 metastatic solid cancer, muscle invasive bladder cancer, localized or
• Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Previously Untreated, Unresectable, or Met … Recruiting
  2025-523224-45-00 10 2026-03-30 Untreated, Unresectable or Metastatic Colorectal Cancer

Showing 217–240 of 1,127 trials